Cowen And Company, LLC Global Blood Therapeutics, Inc. Call Options Transaction History

Cowen And Company, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	SELL	$25.68 - $35.59 $308,160 - $427,080	-12,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$24.9 - $40.26 $298,800 - $483,120	12,000 New	12,000 $13,000
Q1 2021 May 04, 2021	SELL	$38.94 - $50.85 $790,482 - $1.03 Million	-20,300 Closed	0 $0
Q4 2020 Feb 08, 2021	BUY	$37.65 - $63.77 $764,295 - $1.29 Million	20,300 New	20,300 $11,000
Q3 2020 Nov 03, 2020	SELL	$52.76 - $74.49 $1.6 Million - $2.26 Million	-30,400 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$48.73 - $81.82 $964,853 - $1.62 Million	19,800 Added 186.79%	30,400 $38,000
Q1 2020 May 11, 2020	BUY	$41.72 - $87.2 $442,232 - $924,320	10,600 New	10,600 $32,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.